Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer. - Test2 - elhamkhani - TriplyDB

Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.

Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.

http://www.wikidata.org/entity/Q37139199

about

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy Lithium Chloride Promotes Apoptosis in Human Leukemia NB4 Cells by Inhibiting Glycogen Synthase Kinase-3 Beta.Glycogen synthase kinase-3: a potential preventive target for prostate cancer management Lithium treatment and cancer incidence in bipolar disorder.β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.Lithium in kidney diseases: big roles for the smallest metal LiCl Treatment Induces Programmed Cell Death of Schwannoma Cells through AKT- and MTOR-Mediated Necroptosis.Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation.

P2860

Q26739711-D096709B-8CAF-4045-8D62-083E1701E061 Q36189756-A3B41030-7805-43F6-BA5A-0F6B1EC38A06 Q36580561-8C2F84CF-5FA6-4555-8A41-829CC6FBCBAF Q40908410-7E9D4339-3208-48F3-AB07-6108807E1B95 Q41985110-B41B3D51-863C-4955-AAD4-E87DD4E64B26 Q42429839-7A8C69AC-D6C5-46ED-93BD-4485E418D33C Q51064099-5D8184C3-2363-4A8C-9B37-3AAAEECAFEA9 Q55168420-0D5BE100-8E88-4BAB-B336-C05B51D37DFA

P2860

Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.

http://www.wikidata.org/entity/Q37139199

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@en

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@nl

type

label

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@en

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@nl

prefLabel

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@en

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@nl

P1433

Q37139199-9461097C-136D-4D9A-B357-931857683BBB

P1476

Q37139199-DC096EBF-B2A4-493F-BF7F-6B4A1BED9C5D

P2093

Q37139199-0F5E4308-2B5D-4F6A-8FBD-C74852BF3376

Q37139199-211CA86A-7A0F-45DD-B0EA-A6BF78B3AEA5

Q37139199-2CADEAF8-EA6B-425F-89B1-DB0ED951767F

Q37139199-68280050-6EF5-486A-A999-A0D5CCB4FAA8

Q37139199-748301DB-04D8-4F16-9B73-7D0ECE69332B

Q37139199-7ACDA8CE-87C8-4752-8488-D4E590C2812C

Q37139199-B75F50C6-77AF-4826-8168-783DCAC5E1A3

P2860

Q37139199-16DDA8CA-485E-43D1-986B-D5EEF1C0B3E5

Q37139199-1A157151-459C-4D59-8011-2EE15249EEAB

Q37139199-1C379DEE-3E6D-4E6D-83A7-DD4AB738762C

Q37139199-20FF0A38-CB58-4BE0-885C-9CE97382E2F3

Q37139199-252365B0-A976-44F5-9306-EF6BC506446A

Q37139199-2528E2FC-7F65-4D38-9D5C-A00830565E8A

Q37139199-2AE25265-10D2-4B43-A0AA-66BF65B41D2E

Q37139199-36F5D2AC-4154-44BC-BC68-6A3AA2DAE7E9

Q37139199-3C5E7919-EBCF-4E83-B395-57330B27A34D

Q37139199-426FC31E-9CE5-49C5-9C86-C18787BF8833

P304

Q37139199-B95F7FC9-56DE-4818-B59A-F16956ACAB8D

P31

Q37139199-B9CBFCAD-49D2-4C2A-9EC0-D56C0BB969F5

P356

Q37139199-9FE10D80-4E4B-4D04-A864-8DFFBDADC514

P407

Q37139199-7D287C0C-BC52-4642-9CCF-35DECD0A916D

P433

Q37139199-7D7D7BD5-BBFA-420E-BED5-507614610DE2

P478

Q37139199-EA7C9E53-2E10-4F8A-B2F0-CD8D466F9A51

P577

Q37139199-9FEC1ACE-7FCD-4094-97AE-4E5A9A86C35C

P5875

Q37139199-54F03C2B-9E7F-4131-92DD-FDFBD4F0B315

P698

Q37139199-947517B9-7541-4121-A4E7-0C651569CDF6

P932

Q37139199-7152E93F-6BFD-46D6-ABEB-B19FDFB68370

P356

P1433

International Journal of Molecular Sciences

P1476

Glycogen synthase kinase 3β in ...... eatment of endometrial cancer.

@en

P2093

Katherine B Chiappinelli

http://www.w3.org/2001/XMLSchema#string

Kathryn M Trinkaus

http://www.w3.org/2001/XMLSchema#string

Liang Ma

http://www.w3.org/2001/XMLSchema#string

Nora T Kizer

http://www.w3.org/2001/XMLSchema#string

Paul J Goodfellow

http://www.w3.org/2001/XMLSchema#string

Premal H Thaker

http://www.w3.org/2001/XMLSchema#string

Yan Yin

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

A molecular mechanism for the effect of lithium on development

Knockin of mutant PIK3CA activates multiple oncogenic pathways

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

p53, the cellular gatekeeper for growth and division

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

P304

16617-16637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS140816617

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255951421

http://www.w3.org/2001/XMLSchema#string

P698

23941783

http://www.w3.org/2001/XMLSchema#string

P932

3759928

http://www.w3.org/2001/XMLSchema#string